| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | 10%+ Owner | Common Stock | 157,387 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 12 Jan 2026 | 8 | +$15,030,000 | 4 | 10%+ Owner | 12 Jan 2026, 17:10 |
| AKTS | Aktis Oncology, Inc. | 08 Jan 2026 | 0 | $0 | 3 | 10%+ Owner | 08 Jan 2026, 20:41 |